Seeing Is Believing
Currently out of the existing stock ratings of Vamil Divan, 184 are a BUY (65.25%), 90 are a HOLD (31.91%), 8 are a SELL (2.84%).
Analyst Vamil Divan works at GUGGENHEIM with a stock forecast success ratio of 61.37% fulfilled within 211.75 days on average.
Vamil Divan’s has documented 596 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ANIP, ANI Pharmaceuticals at 23-Apr-2024.
Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for PFE (PFIZER) at 11/4/2021. The price target of $44 was fulfilled within 1 day with a profit of $3.97 (9.92%) receiving and performance score of 99.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
195
$27.2 (16.21%)
185
29 days ago
10/12 (83.33%)
$14.65 (8.12%)
191
Buy
189
$21.2 (12.63%)
181
2 months 19 days ago
9/11 (81.82%)
$15.71 (9.07%)
252
Buy
195
$27.2 (16.21%)
180
2 months 19 days ago
9/10 (90%)
$21.71 (12.53%)
445
Hold
165
$-2.8 (-1.67%)
157
3 months 8 days ago
11/11 (100%)
$2.96 (1.83%)
314
Buy
180
$12.2 (7.27%)
195
3 months 22 days ago
3/5 (60%)
$21.06 (13.25%)
496
Which stock is Vamil Divan is most bullish on?
Which stock is Vamil Divan is most reserved on?
What Year was the first public recommendation made by Vamil Divan?